Nikolas K Haass - JoVE Visualize

Showing results (71-80 of 82) with videos related to

Pageof 9

Sort By:

Ebiomedicine|January 26, 2017

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITFMitchell E Fane, Yash Chhabra, David E J Hollingsworth, et al.

Cell Death & Disease|April 26, 2019

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survivalErinna F Lee, Tiffany J Harris, Sharon Tran, et al.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 28, 2023

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferaseDinoop Ravindran Menon, Heinz Hammerlindl, Gregory Gimenez, et al.

British Journal of Cancer|April 7, 2026

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.

EMBO Molecular Medicine|June 14, 2017

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.

Neuron|February 17, 2024

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia miceYazi D Ke, Annika van Hummel, Carol Au, et al.

Cancer Research|August 16, 2013

A novel class of anticancer compounds targets the actin cytoskeleton in tumor cellsJustine R Stehn, Nikolas K Haass, Teresa Bonello, et al.

Cell Death and Differentiation|July 10, 2026

S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancersRituparna Bhatt, Si En Ong, Dan A Erkes, et al.

International Journal of Cancer|December 18, 2018

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomesDajiang Guo, Goldie Y L Lui, Siew Li Lai, et al.

The British Journal of Dermatology|March 7, 2023

The MC1R r allele does not increase melanoma risk in MITF E318K carriersCourtney K Wallingford, Anastassia Demeshko, Asha Krishnankutty Krishnakripa, et al.

Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:

Pageof 9

Ebiomedicine|January 26, 2017

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITFMitchell E Fane, Yash Chhabra, David E J Hollingsworth, et al.

Cell Death & Disease|April 26, 2019

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survivalErinna F Lee, Tiffany J Harris, Sharon Tran, et al.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 28, 2023

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferaseDinoop Ravindran Menon, Heinz Hammerlindl, Gregory Gimenez, et al.

British Journal of Cancer|April 7, 2026

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancerZhen Zeng, Anastasia Gandini, Rituparna Bhatt, et al.

EMBO Molecular Medicine|June 14, 2017

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failureMichael P Smith, Emily J Rowling, Zsofia Miskolczi, et al.

Neuron|February 17, 2024

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia miceYazi D Ke, Annika van Hummel, Carol Au, et al.

Cancer Research|August 16, 2013

A novel class of anticancer compounds targets the actin cytoskeleton in tumor cellsJustine R Stehn, Nikolas K Haass, Teresa Bonello, et al.

Cell Death and Differentiation|July 10, 2026

S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancersRituparna Bhatt, Si En Ong, Dan A Erkes, et al.

International Journal of Cancer|December 18, 2018

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomesDajiang Guo, Goldie Y L Lui, Siew Li Lai, et al.

The British Journal of Dermatology|March 7, 2023

The MC1R r allele does not increase melanoma risk in MITF E318K carriersCourtney K Wallingford, Anastassia Demeshko, Asha Krishnankutty Krishnakripa, et al.

Pageof 9